'Chemical architects' design metal-organic framework for drug delivery; Coating cloaks delivery devices from immune system;

> "Chemical architects" at the University of Pittsburgh have designed a metal-organic framework that forms porous structures capable of improved drug delivery, as well as gas storage and transport. More

> A "stealth character" coating for medical devices and drug-delivery systems could help cloak them, disguising the devices from the immune system. Story

> Researchers at the University of California, Berkeley, isolated a virus to target and deliver gene therapy to retinal cells in mice, a less invasive and more precise treatment for blindness. Report

> SurModics ($SRDX) entered a license agreement with Clinuvel Pharmaceuticals, providing Clinuvel with its biodegradable polymer implant technology for the treatment of sun-induced skin disorders. Release

> The FDA accepted IntelGenx's ($IGXT) new drug application for an oral thin-film migraine treatment, which disintegrates rapidly and releases the drug Rizatriptan. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.